Deep Learning-Based Pathogenicity Classifier for Promoter Single Nucleotide Variants (pSNVs)
Patent №
US 12,619,875
Granted
2026-05-05
Filed 2023
Owner
Illumina, Inc.
Lab
—
AI components
0
Assignment
None on record
Dataset
AIPD
Application
18513367
We disclose computational models that alleviate the effects of human ascertainment biases in curated pathogenic non-coding variant databases by generating pathogenicity scores for variants occurring in the promoter regions (referred to herein as promoter single nucleotide variants (pSNVs)). We train deep learning networks (referred to herein as pathogenicity classifiers) using a semi-supervised approach to discriminate between a set of labeled benign variants and an unlabeled set of variants that were matched to remove biases.
Ownership
Illumina, Inc.